NCT01900106View on ClinicalTrials.gov

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
HIV Infection
Interventions
DRUG

abacavir/lamivudine + raltegravir

abacavir/lamivudine + raltegravir

DRUG

abacavir/lamivudine + darunavir/ritonavir

abacavir/lamivudine + darunavir/ritonavir

Trial Locations (1)

41124

University of Modena and Reggio Emilia, Modena

All Listed Sponsors
lead

University of Modena and Reggio Emilia

OTHER

NCT01900106 - A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) | Biotech Hunter | Biotech Hunter